MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. HCA
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

HCA Healthcare (HCA) Financial Metrics 2020-2026

Key metrics and charts across all fundamental categories.

Prices

Stock price and market valuation

Stock Price
$410.50
18.8%
Market Cap
$91.78B
7.6%

HCA trades at $410.5, a 18.8% increase year-over-year. Market capitalization stands at $91.78B, up 7.6% from the prior year. Track HCA price trends and market cap history to understand how the market values this company over time.

Stock Price
How the market values the company over time
Market Cap
Total equity value as determined by the market

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares across quarters

TTM Revenue
$76.39B
6.7%
Q. Revenue
$19.11B
TTM EBITDA
$13.38B
11.7%
TTM Op. Income
$9.79B
13.8%
Q. Op. Income
$2.29B
TTM Net Income
$6.79B
17.6%
Q. Net Income
$1.62B
EPS
$7.25
Shares Out.
$223.59M
9.5%
$76.39B in TTM revenue grew 6.7% YoY, reaching $19.11B last quarter. TTM EBITDA of $13.38B and TTM operating income of $9.79B shows growth is flowing through. Net income of $6.79B TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.
TTM Revenue
Reveals whether the core business is growing or shrinking
Quarterly Revenue
Highlights seasonal patterns and short-term momentum
TTM EBITDA
Shows if underlying operating profitability is improving
Quarterly EBITDA
Tracks near-term operating profitability trends
TTM Operating Income
Smoothed operating profit over the past four quarters
Quarterly Operating Income
Profit from core operations before financing costs
TTM Net Income
The bottom line — is the company making more money?
Quarterly Net Income
Short-term profit after all expenses and taxes
EPS
Earnings per share — profit attributable to each share
Shares Outstanding
Declining means buybacks benefit remaining holders

Assets & Liabilities

Assets, cash, debt, book value, and leverage

Total Assets
$61.45B
Cash
$940.00M
Long-Term Debt
$39.49B
Book Value
$-6.30B
D/E Ratio
N/A
Debt/EBITDA
12.3
Total Assets
Expanding asset base can indicate business growth
Cash & Equivalents
Shows liquidity available for opportunities or downturns
Long-Term Debt
Declining debt trend is generally positive
Book Value (Equity)
Growing book value signals intrinsic value creation
Debt / Equity
Lower means less reliance on borrowed money
Debt / EBITDA
Below 2x is conservative; above 4x is high

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow
$2.01B
Free Cash Flow
$895.00M
35.6%
FCF Margin
1.2%
FCF / Net Income
0.6
FCF of $895.00M on $2.01B in operating cash flow. The FCF / Net Income ratio of 0.1x indicates partial cash conversion — earnings quality needs attention.
Operating Cash Flow
Cash generated from core business operations
Free Cash Flow
Cash the business generates after maintaining itself
FCF Margin (%)
10%+ signals a capital-efficient business model
FCF / Net Income
Above 1 means earnings are backed by real cash

Margins

Profit margins across the income statement

EBITDA Margin
16.8%
Op. Margin
12.0%
5.8%
Net Margin
8.5%
3.5%
Op. margin of 12.0% is down 0.7% YoY — costs are rising relative to revenue. Net margin at 8.5%.
Gross Margin (%)
Revenue left after direct cost of goods sold
EBITDA Margin (%)
Operating profitability independent of capital structure
Operating & Net Margins (%)
How much of each dollar becomes profit

Price Ratios

Valuation multiples — is the company cheap or expensive?

P/E Ratio
13.5x
P/S Ratio
1.2x
P/B Ratio
N/A
At 13.5x P/E, the stock trades below market averages — potentially undervalued. P/S of 1.2x and P/B of 0.0x provide additional context. Below-market P/E with growing revenue suggests a potential buying opportunity — the stock may be undervalued relative to its fundamentals.
P/E Ratio
Higher suggests growth expectations; lower may signal undervaluation
P/S Ratio
Useful when earnings are volatile or negative
P/B Ratio
Below 1 means trading below accounting book value
EV / EBITDA
Lower multiple often signals better value
FCF Yield (%)
Cash return at current price — compare to bond yields
Earnings Yield (%)
Earnings return at current price — inverse of P/E

Others

Return ratios, efficiency, and credit metrics

ROE
N/A
ROA
11.1%
Asset Turnover
1.2
Rev/Share
$341.65
Interest Coverage
3.9
ROA of 11.1% shows how efficiently management uses assets to generate profit. Revenue per share at $341.646 removes dilution effects from top-line growth. Interest coverage of 3.9x indicates adequate but not generous interest coverage.
Return on Equity (ROE)
15%+ consistently signals a durable competitive advantage
Return on Assets (ROA)
How well management uses assets to generate profit
Asset Turnover
How efficiently assets generate each dollar of sales
Revenue per Share
Per-share revenue growth adjusted for dilution
Interest Coverage
How comfortably the company covers interest payments